Skip to Main Content

Paper Details

Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
Mol Cancer Ther
74
2016
ABCB1, ATP, Dox, Dox-resistant/Pgp-, Dox-resistant/Pgp-overexpressing cells, Doxorubicin, Doxorubicin-Resistant Osteosarcoma, P-glycoprotein, Pgp, anthracyclines, doxorubicin, drug, drug-resistant osteosarcoma, high-grade osteosarcoma, mitochondria-related genes, mtDox, osteosarcoma, osteosarcoma cells, osteosarcomas, oxygen, patients, resistant osteosarcoma cells, tumor, tumor cells
Author NameAffiliation
Iris Chiara SalaroglioUniversity of Torino
Claudia Maria HattingerOrthopaedic Rizzoli Institute, Pharmacogenomics and Pharmacogenetics Research Unit
Claudia Maria HattingerOrthopaedic Rizzoli Institute, Pharmacogenomics and Pharmacogenetics Research Unit
Massimo SerraOrthopaedic Rizzoli Institute, Pharmacogenomics and Pharmacogenetics Research Unit
Massimo SerraOrthopaedic Rizzoli Institute, Pharmacogenomics and Pharmacogenetics Research Unit
Chiara RigantiUniversity of Torino
  • 1 - 6

Datasets

Release 1.2